AK

Arun Kumar

Director Director DIN 09008470
DIN 09008470 First appointment Aug 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Arun Kumar

Data last updated:

Arun Kumar was a Director at Vatsalya Institute Of Medical Sciences (2016–2021) and Managing Director at Imuntech Life Sciences Private Limited (from 2020). The companies operate in Healthcare.

DIN 09008470
Primary Designation Director
Industry Healthcare
First Appointment 10 Aug 2016
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Aug 20162014₹31.1 Lakh (FY 2018)Active
Managing Director24 Dec 20202020₹60,570 (FY 2022)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Imuntech Life Sciences Private Limited
Vatsalya Institute Of Medical Sciences
Premium access

Shareholding and investment profile for Arun Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Kumar

Arun Kumar was first appointed on 10 Aug 2016 as Director at Vatsalya Institute Of Medical Sciences. The most recent appointment on record is 24 Dec 2020 at Imuntech Life Sciences Private Limited.

Arun Kumar held 2 earlier board appointments: Vatsalya Institute Of Medical Sciences (Director, 10 Aug 2016 to 29 Nov 2021); Imuntech Life Sciences Private Limited (Managing Director, from 24 Dec 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available